bimatoprost 0.03 % Ophthalmic Solution
- RxCUI
- 308739
- RxNorm name
- bimatoprost 0.03 % Ophthalmic Solution
- Display name
- bimatoprost 0.03 % Ophthalmic Solution
- Full name
- bimatoprost 0.03 % Ophthalmic Solution
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:12
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BIMATOPROST | BIMATOPROST | NuCare Pharmaceuticals,Inc. | 19b21ff7-847c-3dc9-e063-6394a90a20cc | 2026-01-09 | Warnings, Adverse reactions | 308739 |
| Bimatoprost | BIMATOPROST | Alembic Pharmaceuticals Inc. | a4f4ecb2-999f-4656-8f94-2f06c6dd7990 | 2025-12-04 | Warnings, Adverse reactions | 308739 |
| Bimatoprost | BIMATOPROST | Apotex Corp. | f5c1c8c6-2a7f-482b-6ecf-9cabd3a6a5c1 | 2025-09-16 | Warnings, Adverse reactions | 308739 |
| Bimatoprost | BIMATOPROST | Somerset Therapeutics, LLC | b2afe664-49b0-4d69-bc89-adddf50b58ba | 2025-03-22 | Warnings, Adverse reactions | 308739 |
| BIMATOPROST | BIMATOPROST | Micro Labs Limited | 8c021e8a-2938-42a7-a17e-2f7f97256344 | 2024-09-26 | Warnings, Adverse reactions | 308739 |
| Bimatoprost | BIMATOPROST | NuCare Pharmaceuticals,Inc. | 147e2ec6-8fb1-ed5a-e063-6294a90a5eca | 2024-03-25 | Warnings, Adverse reactions | 308739 |
| Bimatoprost | BIMATOPROST | Alembic Pharmaceuticals Limited | f471cb1d-57c7-4556-99af-68f8c96059fd | 2023-08-25 | Warnings, Adverse reactions | 308739 |
| bimatoprost | BIMATOPROST | Alembic Pharmaceuticals Limited | 2b4107e4-c108-4ed5-b7e8-253b74f2ff25 | 2023-07-19 | Warnings, Adverse reactions | 308739 |
| Bimatoprost | BIMATOPROST | Aurobindo Pharma Limited | 059a60ec-aee2-4c13-8307-05cd92e8729a | 2023-07-17 | Warnings, Adverse reactions | 308739 |
| Bimatoprost | BIMATOPROST | Fosun Pharma USA Inc. | 2f9ee30a-1737-44b2-8479-79a3ee88bf5b | 2022-06-09 | Warnings, Adverse reactions | 308739 |
| Bimatoprost | BIMATOPROST | Gland Pharma Limited | 2a4b5b6b-fc47-40d2-8396-ff60511a4cd1 | 2022-04-12 | Warnings, Adverse reactions | 308739 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a4f4ecb2-999f-4656-8f94-2f06c6dd7990 | bimatoprost 0.3 MG/ML Ophthalmic Solution | SCD | 13 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | 20251204 |
| a4f4ecb2-999f-4656-8f94-2f06c6dd7990 | bimatoprost 0.03 % Ophthalmic Solution | SY | 13 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | 20251204 |
| a4f4ecb2-999f-4656-8f94-2f06c6dd7990 | bimatoprost 0.03 % Ophthalmic Solution | PSN | 13 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | 20251204 |
| b2afe664-49b0-4d69-bc89-adddf50b58ba | bimatoprost 0.03 % Ophthalmic Solution | SY | 11 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION 0.03%. BIMATOPROST ophthalmic solution 0.03%, for topical ophthalmic use Initial U.S. Approval: 2001 | 20250322 |
| b2afe664-49b0-4d69-bc89-adddf50b58ba | bimatoprost 0.03 % Ophthalmic Solution | PSN | 11 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION 0.03%. BIMATOPROST ophthalmic solution 0.03%, for topical ophthalmic use Initial U.S. Approval: 2001 | 20250322 |
| b2afe664-49b0-4d69-bc89-adddf50b58ba | bimatoprost 0.3 MG/ML Ophthalmic Solution | SCD | 11 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION 0.03%. BIMATOPROST ophthalmic solution 0.03%, for topical ophthalmic use Initial U.S. Approval: 2001 | 20250322 |
| 8c021e8a-2938-42a7-a17e-2f7f97256344 | bimatoprost 0.03 % Ophthalmic Solution | PSN | 9 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2001 | 20240926 |
| 8c021e8a-2938-42a7-a17e-2f7f97256344 | bimatoprost 0.03 % Ophthalmic Solution | SY | 9 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2001 | 20240926 |
| 8c021e8a-2938-42a7-a17e-2f7f97256344 | bimatoprost 0.3 MG/ML Ophthalmic Solution | SCD | 9 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2001 | 20240926 |
| ec9097e7-4be4-4e62-99c3-24b48244c9f2 | bimatoprost 0.3 MG/ML Ophthalmic Solution | SCD | 9 | Lumigan 03 | 20181207 |
| ec9097e7-4be4-4e62-99c3-24b48244c9f2 | bimatoprost 0.03 % Ophthalmic Solution | SY | 9 | Lumigan 03 | 20181207 |
| ec9097e7-4be4-4e62-99c3-24b48244c9f2 | bimatoprost 0.03 % Ophthalmic Solution | PSN | 9 | Lumigan 03 | 20181207 |
| f5c1c8c6-2a7f-482b-6ecf-9cabd3a6a5c1 | bimatoprost 0.03 % Ophthalmic Solution | SY | 7 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2001 | 20250916 |
| f5c1c8c6-2a7f-482b-6ecf-9cabd3a6a5c1 | bimatoprost 0.3 MG/ML Ophthalmic Solution | SCD | 7 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2001 | 20250916 |
| f5c1c8c6-2a7f-482b-6ecf-9cabd3a6a5c1 | bimatoprost 0.03 % Ophthalmic Solution | PSN | 7 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2001 | 20250916 |
| 2f9ee30a-1737-44b2-8479-79a3ee88bf5b | bimatoprost 0.03 % Ophthalmic Solution | PSN | 6 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION0N, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | 20220609 |
| 2f9ee30a-1737-44b2-8479-79a3ee88bf5b | bimatoprost 0.3 MG/ML Ophthalmic Solution | SCD | 6 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION0N, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | 20220609 |
| 2f9ee30a-1737-44b2-8479-79a3ee88bf5b | bimatoprost 0.03 % Ophthalmic Solution | SY | 6 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION0N, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | 20220609 |
| 2a4b5b6b-fc47-40d2-8396-ff60511a4cd1 | bimatoprost 0.3 MG/ML Ophthalmic Solution | SCD | 6 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | 20220412 |
| 2a4b5b6b-fc47-40d2-8396-ff60511a4cd1 | bimatoprost 0.03 % Ophthalmic Solution | SY | 6 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | 20220412 |
| 2a4b5b6b-fc47-40d2-8396-ff60511a4cd1 | bimatoprost 0.03 % Ophthalmic Solution | PSN | 6 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | 20220412 |
| 19b21ff7-847c-3dc9-e063-6394a90a20cc | bimatoprost 0.03 % Ophthalmic Solution | PSN | 5 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2001 | 20260109 |
| 19b21ff7-847c-3dc9-e063-6394a90a20cc | bimatoprost 0.3 MG/ML Ophthalmic Solution | SCD | 5 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2001 | 20260109 |
| 19b21ff7-847c-3dc9-e063-6394a90a20cc | bimatoprost 0.03 % Ophthalmic Solution | SY | 5 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2001 | 20260109 |
| 059a60ec-aee2-4c13-8307-05cd92e8729a | bimatoprost 0.3 MG/ML Ophthalmic Solution | SCD | 2 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution 0.03%, for topical ophthalmic use Initial U.S. Approval: 2001 | 20230717 |
| 059a60ec-aee2-4c13-8307-05cd92e8729a | bimatoprost 0.03 % Ophthalmic Solution | PSN | 2 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution 0.03%, for topical ophthalmic use Initial U.S. Approval: 2001 | 20230717 |
| 059a60ec-aee2-4c13-8307-05cd92e8729a | bimatoprost 0.03 % Ophthalmic Solution | SY | 2 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution 0.03%, for topical ophthalmic use Initial U.S. Approval: 2001 | 20230717 |
| 6094c742-7cea-429d-8d21-b7cbf8bfe1bd | bimatoprost 0.03 % Ophthalmic Solution | PSN | 2 | These highlights do not include all the information needed to use LUMIGAN ® 0.01% and 0.03% (bimatoprost ophthalmic solution) safely and effectively. See full prescribing information for LUMIGAN ® . LUMIGAN ® 0.01% and 0.03% (bimatoprost ophthalmic solution) Initial U.S. Approval: 2001 | 20100831 |
| 6094c742-7cea-429d-8d21-b7cbf8bfe1bd | bimatoprost 0.03 % Ophthalmic Solution | SY | 2 | These highlights do not include all the information needed to use LUMIGAN ® 0.01% and 0.03% (bimatoprost ophthalmic solution) safely and effectively. See full prescribing information for LUMIGAN ® . LUMIGAN ® 0.01% and 0.03% (bimatoprost ophthalmic solution) Initial U.S. Approval: 2001 | 20100831 |
| 6094c742-7cea-429d-8d21-b7cbf8bfe1bd | bimatoprost 0.3 MG/ML Ophthalmic Solution | SCD | 2 | These highlights do not include all the information needed to use LUMIGAN ® 0.01% and 0.03% (bimatoprost ophthalmic solution) safely and effectively. See full prescribing information for LUMIGAN ® . LUMIGAN ® 0.01% and 0.03% (bimatoprost ophthalmic solution) Initial U.S. Approval: 2001 | 20100831 |
| 147e2ec6-8fb1-ed5a-e063-6294a90a5eca | bimatoprost 0.03 % Ophthalmic Solution | SY | 1 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION0N, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | 20240325 |
| 147e2ec6-8fb1-ed5a-e063-6294a90a5eca | bimatoprost 0.03 % Ophthalmic Solution | PSN | 1 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION0N, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | 20240325 |
| 147e2ec6-8fb1-ed5a-e063-6294a90a5eca | bimatoprost 0.3 MG/ML Ophthalmic Solution | SCD | 1 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION0N, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | 20240325 |
| f471cb1d-57c7-4556-99af-68f8c96059fd | bimatoprost 0.03 % Ophthalmic Solution | SY | 1 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | 20230825 |
| f471cb1d-57c7-4556-99af-68f8c96059fd | bimatoprost 0.3 MG/ML Ophthalmic Solution | SCD | 1 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | 20230825 |
| f471cb1d-57c7-4556-99af-68f8c96059fd | bimatoprost 0.03 % Ophthalmic Solution | PSN | 1 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | 20230825 |
| 2b4107e4-c108-4ed5-b7e8-253b74f2ff25 | bimatoprost 0.03 % Ophthalmic Solution | SY | 1 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution for topical ophthalmic use. Initial U.S. Approval: 2001 | 20230719 |
| 2b4107e4-c108-4ed5-b7e8-253b74f2ff25 | bimatoprost 0.03 % Ophthalmic Solution | PSN | 1 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution for topical ophthalmic use. Initial U.S. Approval: 2001 | 20230719 |
| 2b4107e4-c108-4ed5-b7e8-253b74f2ff25 | bimatoprost 0.3 MG/ML Ophthalmic Solution | SCD | 1 | These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution for topical ophthalmic use. Initial U.S. Approval: 2001 | 20230719 |